The federal legal status of hemp-derived THC products is facing a major shift later this year. Under legislation signed by Congress in late 2025, a new federal definition of “hemp” is scheduled to take effect on November 12, 2026. The change replaces the current framework established under the 2018 Farm Bill and dramatically tightens allowable THC thresholds for hemp-derived products.
If implemented as written, the law would effectively prohibit most hemp-derived THC beverages, edibles, and cannabinoid products currently sold in the United States — including many products containing THC derived from hemp, and other hemp-based cannabinoids. The legislation also imposes an extremely restrictive “total THC” standard and a 0.4 milligram THC cap for finished products, a threshold that many argue is unworkable.
In response, industry groups, retailers, consumer advocates, and some lawmakers have launched efforts to delay, amend, or overturn the upcoming restrictions. Multiple proposals have been introduced in Congress to preserve regulated access to hemp-derived cannabinoid products while establishing stronger safety, testing, labeling, and age-verification standards. Advocates argue that responsible regulation — rather than prohibition — is the appropriate path forward for an industry that has grown rapidly under existing federal law.
The American Alternative Care Policy Network believes hemp-derived THC products should be evaluated through an evidence-based public health and wellness framework rather than broad prohibition. AACPN supports responsible regulation, rigorous product safety standards, age restrictions, accurate labeling, and continued scientific research into cannabinoids and alternative care therapies.
AACPN also believes policymakers should recognize the growing role hemp-derived products may play for adults seeking alternatives related to stress management, trauma recovery support, sleep quality, behavioral health, and alcohol harm reduction — including among veterans, first responders, and other trauma-affected populations.
As federal policymakers continue debating the future of hemp regulation, AACPN supports a balanced approach that protects consumers while preserving lawful access to responsibly manufactured cannabinoid products.